LHCG:NGS-LHC Group

EQUITY | Medical Care | Nasdaq Global Select

Last Closing

USD 122.91

Change

-2.50 (-1.99)%

Market Cap

USD 0.79B

Volume

0.23M

Analyst Target

USD 125.27
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Medical Care

ETFs Containing LHCG

OLD 0.00 % 0.50 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 30.92% 83% B 78% C+
Dividend Return N/A N/A N/A N/A F
Total Return 30.92% 83% B 77% C+
Trailing 12 Months  
Capital Gain 41.57% 83% B 92% A
Dividend Return N/A N/A N/A N/A F
Total Return 41.57% 83% B 92% A
Trailing 5 Years  
Capital Gain 463.81% 63% D 97% N/A
Dividend Return N/A N/A N/A N/A F
Total Return 463.81% 63% D 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 41.40% 73% C 87% B+
Dividend Return 41.40% 73% C 86% B+
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 30.77% 73% C 45% F
Risk Adjusted Return 134.54% 100% F 98% N/A
Market Capitalization 0.79B 92% A 87% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.10 55% 21%
Price/Book Ratio 2.84 38% 39%
Price / Cash Flow Ratio 0.00 31% 23%
Price/Free Cash Flow Ratio 0.00 31% 16%
Management Effectiveness  
Return on Equity 9.63% 64% 68%
Return on Invested Capital N/A N/A N/A
Return on Assets 7.73% 85% 90%
Debt to Equity Ratio 17.92% 25% 67%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.